PharVision Advisers LLC Purchases Shares of 81,429 Nu Skin Enterprises, Inc. (NYSE:NUS)

PharVision Advisers LLC purchased a new stake in Nu Skin Enterprises, Inc. (NYSE:NUS) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 81,429 shares of the company’s stock, valued at approximately $561,000. Nu Skin Enterprises comprises 0.5% of PharVision Advisers LLC’s investment portfolio, making the stock its 28th biggest position. PharVision Advisers LLC owned approximately 0.16% of Nu Skin Enterprises at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Franklin Resources Inc. grew its stake in Nu Skin Enterprises by 6.5% in the 4th quarter. Franklin Resources Inc. now owns 34,307 shares of the company’s stock worth $236,000 after acquiring an additional 2,091 shares during the period. Price T Rowe Associates Inc. MD lifted its stake in shares of Nu Skin Enterprises by 5.3% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 53,711 shares of the company’s stock worth $371,000 after purchasing an additional 2,702 shares during the period. Russell Investments Group Ltd. boosted its holdings in shares of Nu Skin Enterprises by 29.5% during the fourth quarter. Russell Investments Group Ltd. now owns 12,146 shares of the company’s stock worth $83,000 after purchasing an additional 2,768 shares during the last quarter. Ballentine Partners LLC grew its position in shares of Nu Skin Enterprises by 15.5% in the fourth quarter. Ballentine Partners LLC now owns 20,856 shares of the company’s stock valued at $144,000 after purchasing an additional 2,800 shares during the period. Finally, Meeder Asset Management Inc. purchased a new stake in shares of Nu Skin Enterprises in the fourth quarter valued at $25,000. 82.84% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Monday, May 12th.

Nu Skin Enterprises Stock Performance

Shares of NUS stock opened at $7.59 on Wednesday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.17 and a current ratio of 1.82. The firm has a market capitalization of $375.04 million, a price-to-earnings ratio of -2.57 and a beta of 0.92. Nu Skin Enterprises, Inc. has a one year low of $5.32 and a one year high of $13.90. The company has a 50 day moving average price of $6.66 and a 200 day moving average price of $7.00.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.15 by $0.08. The company had revenue of $364.49 million during the quarter, compared to analysts’ expectations of $352.06 million. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. Sell-side analysts anticipate that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current year.

Nu Skin Enterprises Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 11th. Stockholders of record on Friday, May 30th will be issued a $0.06 dividend. The ex-dividend date is Friday, May 30th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 3.16%. Nu Skin Enterprises’s dividend payout ratio (DPR) is -30.00%.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.